Section of Neonatology, Department of Pediatrics, School of Medicine, University of Colorado, Aurora, Colorado;
Department of Pediatrics, Oregon Health & Science University, Portland, Oregon.
Pediatrics. 2018 Aug;142(2). doi: 10.1542/peds.2017-4069. Epub 2018 Jul 3.
To assess the risk of adverse health outcomes for infants after assisted reproductive technology (ART)-treated and subfertile as compared with fertile deliveries.
Live-born singleton infants ≥23 weeks' gestational age (GA) born in Massachusetts between July 1, 2004, and December 31, 2010, were analyzed by linking a clinical ART database with state vital records. χ tests were used to compare the outcomes of fertile (those without ART treatment or other indicators of infertility), subfertile (indicators of infertility, no ART), and ART-treated (linked to ART deliveries) mothers, stratified by GA. Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) were calculated by using multivariate logistic regression within each GA stratum, controlling for maternal sociodemographic and health characteristics.
Compared with infants of fertile mothers ( = 336 705), infants born to subfertile ( = 5043) or ART-treated ( = 8375) mothers were more likely to be preterm (aOR 1.39 [95% CI 1.26-1.54] and aOR 1.72 [95% CI 1.60-1.85], respectively) and have respiratory and gastrointestinal and/or nutritional conditions (aOR range: 1.12-1.18). When stratified by GA, infants of subfertile or ART-treated mothers were at greater risk for congenital malformations and infectious diseases as well as cardiovascular and respiratory conditions (aOR range: 1.30-2.61; 95% CI range: 1.02-4.59). Compared with infants born to subfertile mothers, infants born to ART-treated mothers were at lower risk for being small for GA and having congenital malformations and cardiovascular conditions and at higher risk for infectious disease conditions.
Compared with infants born to fertile mothers, infants of subfertile and ART-treated mothers are at greater risk for adverse health outcomes at birth beyond prematurity. The occurrence and magnitude of these risks vary by GA and organ systems.
评估辅助生殖技术(ART)治疗后与生育力低下的婴儿与正常分娩婴儿相比不良健康结局的风险。
通过将临床 ART 数据库与州生命记录相链接,对 2004 年 7 月 1 日至 2010 年 12 月 31 日期间在马萨诸塞州出生的≥23 周妊娠龄(GA)的活产单胎婴儿进行分析。χ2 检验用于比较有生育能力(无 ART 治疗或其他不孕指标)、生育力低下(不孕指标,无 ART)和接受 ART 治疗(与 ART 分娩相关)母亲的结局,并按 GA 分层。在每个 GA 分层内,通过多变量逻辑回归控制母体社会人口统计学和健康特征,计算调整后的优势比(aOR)和 95%置信区间(CI)。
与生育能力正常的母亲所生婴儿(n=336705)相比,生育力低下或接受 ART 治疗的母亲所生婴儿更可能早产(aOR 1.39[95%CI 1.26-1.54]和 aOR 1.72[95%CI 1.60-1.85]),且呼吸、胃肠道和/或营养状况更差(aOR 范围:1.12-1.18)。按 GA 分层时,生育力低下或接受 ART 治疗的母亲所生婴儿先天畸形、感染性疾病以及心血管和呼吸系统疾病的风险更高(aOR 范围:1.30-2.61;95%CI 范围:1.02-4.59)。与生育力低下的母亲所生婴儿相比,接受 ART 治疗的母亲所生婴儿发生小于胎龄儿和先天畸形以及心血管疾病的风险较低,而发生感染性疾病的风险较高。
与生育能力正常的母亲所生婴儿相比,生育力低下和接受 ART 治疗的母亲所生婴儿的出生时不良健康结局的风险更高,除早产外,还包括其他不良结局。这些风险的发生和程度因 GA 和器官系统而异。